Hepatitis B Re-Engagement Efforts Underreported in Lower-Resource Settings: Helen Nde, MPHByBrooke McCormick,Helen Nde, MPH,Laura Joszt, MAAugust 17th 2026
Lifestyle Factors Offer Actionable Targets in MASLD Management: Zobair M. Younossi, MDByBrooke McCormick,Zobair M. Younossi, MD,Laura Joszt, MAAugust 16th 2026
Tobevibart Combo Shows High Hepatitis D Efficacy: Tarik Asselah, MD, PhDByBrooke McCormick,Tarik Asselah, MD, PhDAugust 12th 2026
Fibrosis-Focused End Points Could Reshape MASH Trial Design: Zobair M. Younossi, MDByBrooke McCormick,Zobair M. Younossi, MD,Laura Joszt, MAAugust 11th 2026